n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 5 1 ( 2 0 1 7 ) 4 5 -5 2 a r t i c l e i n f o We continuously look for new techniques to improve the radicality of resection and to eliminate the negative effects of surgery. One of the methods that has been implemented in the perioperative management of Cushing's disease was the combination of three magnetic resonance imaging (MRI) sequences: SE, SPGR and fSPGR. Material and methods: We enrolled 41 patients (11 males, 30 females) diagnosed with Cushing's disease. A 3D tumour model with a navigation console was developed using each SPGR, fSPGR and SE sequence. The largest model was then used. In all cases, a standard fourhanded, bi-nostril endoscopic endonasal technique was used. Endocrinological follow-up evaluation using morning cortisol sampling was performed for 6-34 months in our study. Results: In total, 36 patients (88%) were disease-free following surgery. Our results indicate we achieved 100% sensitivity of MR. Overall, the conformity of at least one donor site, as compared with the places designated on MR, was in 78% of patients. We searched the place of compliance in individual locations. There is a consensus in individual locations in 63 of the 123 cases (or 56%). The correlation gamma function at a 5% significance level was then 0.27. Discussion: The combination of MR sequences (SE, SPGR, fSPGR), neuronavigation system and iMRI led to increased sensitivity of up to 100%. Specificity reached 56% in our study. Conclusion: We found a high success rate in surgical procedure in terms of the correlation between MR findings and histology, which leads to remission of Cushing's disease. #
Introduction
Cushing's disease or central Cushing's syndrome is a condition of an increase in cortisone in the blood level caused by a benign pituitary tumour secreting adrenocorticotropic hormone (ACTH). In 1910, Harvey Cushing performed the first transsphenoidal surgery for pituitary adenoma using sublabial incision [1, 2] . However, in 1925, Cushing replaced the transsphenoidal approach with the transcranial approach. Cushing's disease was first described by Harvey Cushing in 1932 [3] . Since then, pituitary surgery has undergone considerable development. The sublabial transsphenoidal approach was not forgotten largely thanks to the work of N. Dott and G. Guiot. The first transsphenoidal surgery in the Central Military Hospital in Prague was performed by E. Černý in 1972. In May 2006, an endoscopic mononostril technique was introduced at Neurosurgical Department of 1st Medical Faculty of Charles University. Since November 2006, a binostril endoscopic technique was employed and since April 2008, intraoperative magnetic resonance imaging (iMRI) has been used. We keep looking for new techniques to improve the radicality of resection, as well as to eliminate negative effects of surgery. One of the methods, that was implemented in the perioperative management of Cushing's disease, was the combination of three magnetic resonance imaging (MRI) sequences (SEspine echo, SPGR -spoiled gradient recalled acquisition in steady state and fSPGR -fast spoiled gradient recalled acquisition). Tumour identification sensitivity of the SPGR sequence alone is 76% and specificity 33% [4] . The aim of our study was to correlate sensitivity and specificity of combined MRI with histological findings.
2.
Material and methods
Cohort characteristics
We enrolled 41 patients (30 males, 11 females) diagnosed with Cushing's disease. The average age at the time of diagnosis was 40 years (range 8-78 years ). If we define microadenoma as a tumour smaller than 524 mm 3 , 36 patients had microadenoma and 5 had macroadenomas in our cohort.
Endocrinological follow-up using morning cortisol sampling was 6-34 months.
Biopsy samples collection
BrainLab iPLAN NET software was used during the whole surgery. Before surgery, the navigation SPGR sequence with gadolinium enhancement was uploaded to the navigation console. A 3D tumour model was designed using each sequence (i.e. SPGR, fSPGR and SE Each MRI was reviewed three times: intial analysis was performed by the radiologist who was on duty on the date of the investigation. The second review was done by the experienced neurosurgeon who was not performing the surgery but has got extensive experience with sellar region analysis on MRI. The third analysis was performed by neuroradiologist with special experience and interest in neuroimaging. Data underwent the final review, tumour volume was depicted and sent into the navigation system.
The Sella turcica was divided horizontally into thirds and labelled zone I (central third), II (left third) and III (right third) (Fig. 1) . During surgery, a biopsy sample of minimum diameter (0.50) mm was carefully collected from each zone (I, II, III), leaving healthy adenohypophysis intact (Fig. 2) . If healthy adenohypophysis were in the zone of biopsy, a sample from the nearest point was collected. After biopsy samples were harvested, the rest of the tumour was resected using a neuronavigation 3D model. The site of histological specimen removal was stored in navigation system in order to analyse the distance of the histological specimen removal and pituitary adenoma according to preoperative MRI.
Standard analysis of histological specimen was performed. Following investigations were performed: hematoxyllin-eosin stain, Wilderś reticulin stain and immunohistochemical stain for ACTH.
Surgical technique
All patients underwent surgery under general anaesthesia. In all cases, a standard four-handed, bi-nostril endoscopic endonasal technique was used. In the sella region, a rigid endoscope with 08 optics Karl Storz (180/4 mm), a highdefinition HD camera and an Aesculap LED light source were employed. A surgical intradural technique is identical to microscopic surgery. We used blunt dissectors as well as sharp curettes. Eventual bleeding was controlled with haemostatic foam in order to keep good access to the biopsy zones. We tried to identify both tumour and adenohypophysis by endoscope and neuronavigation. In all patients, 3.0T iMRI was performed. Standard MRI follow-up was scheduled on postoperative day 1, day 90 (3 months), 9 months after and then periodically once a year.
Results
(A) Disease remission during the follow-up period and correlation between MRI and histology (1) In total, 36 patients (88%) were disease-free after surgery.
(2) Full concordance between MRI and histological findings (i.e. all sites positive according to MRI were positive according to histology and vice versa, all negative sites according to MRI were negative according to histology) occurred in 8 cases (20%). In these 8 cases, disease remission was achieved in all 8 patients and the morning cortisol level was 23-462 mmol/l (Fig. 3) . (3) No agreement between MRI findings and histology (i.e.
there was a different adenoma location than according to MRI) was observed in 9 patients (22%). (4) The agreement on one point or more but not a complete match between MRI sites of adenoma and histological findings occurred in 24 patients (58%). Overall, the conformity of at least one donor site, in comparison with the places designated (the sum of the full match and at least one point of compliance) on MRI, occurred in 78% of the patients.
(a) Larger histology findings than those displayed on the MRI (i.e. there were positive samples from peripheral areas outside the findings displayed on MRI -tumour exceeded the area shown on MRI by histology) was observed in 21 patients, i.e. 51%. In case of histology findings larger than the findings displayed on the MRI, then normalisation of morning serum cortisol level was observed at 19 in 21 patients (i.e. 90%). In these cases serum cortisol was between 6 nmol/L and 551 nmol/L in the follow-up period. Surgery was unsuccessful in two patients with histological findings exceeding the MRI findings. Their endocrinological levels were 649 nmol/L and 870 nmol/L. There were 8 cases of full concordance of MRI and histological findings and 21 cases when histology was exceeding the MRI findings.
Endocrinological remission was achieved in 27 patients out of 29 these patients (93%) (Figs. 4 and 5). (b) Less extensive histology findings (i.e. there were negative samples taken in place of MRI findings) were found in three patients (7%). If the histology were less extensive (i.e. there were negative samples taken in place of MRI findings or not any positive sample), then there was endocrinological remission in 1 of the 3 cases (33%) (Figs. 6 and 7) . Each sampling area was shared and compared with similar areas of histological positivity for statistical calculations. We searched places of consensus in various areas (Table 1) .
There is a consensus in individual locations in 63 of the 123 cases, i.e. 56%, as seen from Table 2 .
Correlation gamma at the 5% significance level was then 0.27. Full compliance (i.e. all combinations consensus) was reached in only 20% per cent of cases (Table 3) . 4.
Discussion
In 1910, Harvey Cushing performed the first transsphenoidal surgery for pituitary adenoma using sublabial incision [1, 2] . In 1925, Cushing replaced the transsphenoidal approach with the transcranial approach. The sublabial transsphenoidal approach continued to be used because of the work of N. Dott and G. Guiot. Dott and Guiot not only adopted the transsphenoidal technique but also introduced intraoperative fluoroscopy. In the same period, J. Hardy made an important breakthrough in pituitary surgery using an operative microscope, which led to the resurrection of the sublabial approach [5] . The first transsphenoidal pituitary surgery in the Central Military Hospital in Prague was performed by E. Černý in 1972. This technique was later improved by I. Fuks and eventually became a standard procedure [6] . In May 2006, the endoscopic endonasal mononostril approach was introduced in the Neurosurgical Department of the 1st Medical Faculty of Charles University. Since November 2006, the binostril endoscopic endonasal technique was employed [7] . The arrival of intraoperative magnetic resonance imaging (iMRI) in April 2008 enabled increased radicality in pituitary surgery [8, 9] .
Four therapeutic modalities are currently available for sellar lesions: observation, neurosurgery, pharmacological treatment and radiosurgery (Leksell Gamma Knife (LGK) is used in the Czech Republic). These four modalities are more complementary than they are contradictory. Modern surgical techniques clearly lead to increased radicality and a decrease in adverse effects [10] .
Radicality is of great importance when evaluating any surgical procedure; in the case of hormonal active adenomas, radicality is defined as a hormone level decrease. To achieve higher radicality, new diagnostic methods are available. For Cushing's disease, diagnosis and adenoma localisation and selective cavernous sinus catheterisation were used. One of the largest studies that tried to show an advantage of cavernous sinus catheterisation over MRI occurred over 20 years ago, in 1994. This paper included 20 patients: catheterisation was unsuccessful in three (12%) of the 20 patients. Concordance of lateralisation of sinus sampling and tumour localisation during surgery were observed in 7 out of 11 (64%) patients without corticotropin-releasing hormone (CRH) stimulation and in 8 out of 11 (73%) patients after CRH stimulation. In 3 out of 12 (25%) patients, lateralisation changed after CRH stimulation [11] . Catheterisation is no longer in practise today because of the arrival of modern imaging techniques such as MRI, computed tomography (CT), positron emission tomography (PET) and sonography.
One study concerning sonographic diagnosis examined 68 patients with negative or inconclusive MRI results. Intraoperative ultrasonography identified tumours in 47 (69%) patients with a negative MRI finding. In three of these 47 patients, no tumour was found by the pathologist in the biopsy sample. Considering the difficult implementation of ultrasound in the surgical process and the need for relatively extensive skills, sonography offers only a more precise localisation of the tumour, but cannot measure the extent and size of the lesion [12] . Based on the above-mentioned data, the best diagnostic option is MRI with an SPGR sequence. One recent paper compared the sequence MRI SPGR, MRI SE and high-resolution positron emission tomography (hrPET). Ten patients were included in that study. MRI identified adenoma in four (40%) patients using SE and in seven (70%) patients using SPGR.
18F-fluorodeoxyglucose (F-FDG) hrPET diagnosed adenoma in four (40%) patients with tumour size 3-14 mm. Thus, hrPET was able to identify small, hormonally active adenomas in Cushing's disease better than SE MRI but not better than SPGR MRI [13] . In conclusion, SPGR MRI thus far is the most effective diagnostic method in Cushing's disease. What is still unknown is whether SPGR is precise enough to allow surgery.
As stated earlier in this paper, SPGR identifies adenoma very well. We do not know how specific and precise it is in diagnosing the extent of adenoma. We must keep in mind that 2 0 1 7 ) 4 5 -5 2 up to 10% of the general population has pituitary adenoma without any clinical signs [14, 15] . In other words, 10% of the population might harbour a hormonally active adenoma in addition to an inactive tumour. However, according to a large series of 660 patients, only 2% had Cushing's disease [16] . Gradient-echo MRI sequences could be divided into the spoiled gradient-echo and steady-state free precession (SSFP) sequence. SPGR or spoiled GRASS are among the spoiled gradient-echo sequences. In this group belongs also fasts PGR, which is an extremely low angle shot. Before the discovery of SPGR, some researchers tried to improve diagnostics using double perfusion of pituitary adenomas from the hypophyseal portal system and the meningohypophyseal trunk in conjunction with dynamic scanning after the application of a contrast agent. These studies showed no significant improvement over conventional MRI [17, 18] . SPGR was first used in 1990 to diagnose Cushing's disease in six patients. Sensitivity was found to be 80% [19] . In another paper assessing diagnostic value in 76 prolactinoma patients, sensitivity was 75%, but only 15 had a surgically confirmed tumour in the depicted region. These patients were those in which hormonal treatment failed [20] . It obviously led to some scepticism on the diagnostic value of SPGR. Many factors are responsible for the seemingly excellent sensitivity and diagnostic precision of SPGR when compared with standard MRI [21] [22] [23] [24] .
The important question remains as to whether SPGR is a suitable tool to plan the extent of resection. In the largest study from 2003 that examined 50 surgical patients. The authors concluded that using SPGR during the planning phase would give false positive results [4] . In this study, sensitivity of detecting a tumour was 76% and specificity only 33%. Radiological examination underestimated the size of the tumour (≤5 mm) when compared with the intraoperative finding (6-10 mm). Despite the exceptional sensitivity of SPGR, precise tumour targeting is not possible.
Our goal was to prove that targeting was possible using a combination of state-of-the-art methods. Accordingly, we used a combination of preoperative MR (SE, SPGR, fSPGR), neuronavigation and iMRI. For pituitary adenoma depiction we followed current recommendations [25] [26] [27] . To a standard SE sequence we added SPGR, fSPGR sequences and analysis of their combinations. The study was surgically focused. Whether the data about the shape of the adenoma can help surgeon in resection of the adenoma. Aside of the presented sequences we used the sequences as recommended by the current review paper on this topic [28] . Therefore we do not discuss in this paper value of diffusion weighted imaging or perfusion weighted imaging in sellar region.
We achieved 100% sensitivity. Particularly noteworthy is that we cooperated with only one department that performs endocrinological examinations, namely the 3rd Medical Department of the 1st Medical Faculty, Charles University. Increased sensitivity could be attributed to the combination of all three MR sequences (SE, SPGR and fSPGR). Using these three sequences, a skilled neuroradiologist with more than 20 years of clinical practice was able to identify tumours in all cases, as well as to define the extent of the tumours and to properly set neuronavigation software. The main issue of specificity of these MR sequences remains.
For statistical analysis, each sampling area was shared and compared with similar areas of histological positivity. We searched the place of compliance in individual locations. There was a consensus in individual locations in 63 of the 123 cases (56%). The correlation gamma function at a 5% significance level was then 0.27. This result translates to a specificity of 56%. The specificity is the certainty of finding a pituitary adenoma at the measuring point. Overall, we are able to increase specificity by a combination of methods specificity of 33% (according to literature) at 56%. Complete agreement, i.e. compliance in all combinations, was achieved in only 20% of the cases. This is the overlap of the tumour outside the viewing area, or conversely, larger findings displayed on MR than findings on postoperative histology. This observation is consistent with the authors of the above-mentioned publications.
If we examine individual findings in our cohort, full concordance of results was attained in eight patients (20%). In 21 patients (51%), histological findings were more extensive than MR imaging, i.e. positive histology samples were found beyond the supposed limits defined by MRI. The opposite result, i.e. histological extent smaller than MRI extent, occurred in three patients (7%). Negative specificity was noted in nine patients (22%). In these cases, the extent of MRI differed from the histological finding. The role played by the number of patients, not statistical consensus at individual points.
Important is the correlation of MRI, histology and endocrinological outcome after surgery. In our study, remission of morning cortisol hypersecretion during the follow-up was achieved in case of the full agreement between MRI and histology in 100%. In this subgroup of complete concordance, the level of morning cortisol was 23-462 nmol/l.
In case of more extensive histological findings than what would be suspected on MRI, morning cortisol hypersecretion was achieved in 21 patients (90%), with serum levels reaching 6-551 nmol/l. There was the borderline between tumour and healthy adenohypophysis was distinct. The tumour was resected beyond the area shown on MRI. As a result, these surgeries led to high radicality of resection. On the other hand, less extensive histology findings (i.e. there were negative samples taken in place of MRI findings) were found in three patients (7%). If the histology were less extensive (i.e. there were negative samples taken in place of MRI findings or there were no positive samples), then there was endocrinological remission in 1 of the 3 cases (33%). There may also include a suitable place of sampling or an insufficiently transparent area to continue resection. Patients with sinus tumour infiltration belong to this group of patients. The overall result (i.e. the extinction morning serum cortisol activity) reached 88% in our group in the follow-up period.
Evidence shows that endocrinological remission after transsphenoidal surgery in Cushing's disease ranges from 79.5% to 89% [29, 30] . iMRI led to a decision to continue with resection in one case (2.5%). Overall radicality is influenced by the relatively short follow-up time, which was 6-42 months in our study. We assume that the natural course of the disease will decrease radicality with time. In our cohort, two patients with high cortisol levels are on hormonal therapy, two patients were irradiated by LGK and one unsuccessfully irradiated patient underwent adrenalectomy.
In our cohort, postoperative CSF leakage occurred in two patients, who subsequently underwent revision surgery, including CSF fistula closure and lumbar drainage insertion. One patient with a chronic sphenoid sinus infection suffered postoperative meningitis without CSF leakage and was treated by antibiotics without need for surgical intervention.
Overall, mortality was 0% and morbidity 7.3% in our cohort. If we include long-term substitution of vasopressin analogue, morbidity reached 14.6%.
Conclusion
The aim of our study was an optimisation of preoperative MR diagnostic protocol in Cushing's disease and to prove its increased diagnostic yield in a prospective trial. Recent studies have shown sensitivity to be 76%, whereas specificity of exact tumour localisation has only been 33%. Our effort was to use a combination of modern diagnostic methods and to show that exact tumour localisation is possible. Combination of MR sequences (SE, SPGR, fSPGR), a neuronavigation system and iMRI resulted in an increase in sensitivity (up to 100%). Specificity reached as high as 56% in our study. We found a high success rate in surgical procedure in terms of the correlation between MR findings and histology, which leads to remission of Cushing's disease. Our results support the use of MR examination together with a navigation system and iMRI.
